Avacta Group Plc (LON:AVCT - Get Free Report)'s stock price traded up 11.6% during mid-day trading on Thursday . The stock traded as high as GBX 39 ($0.53) and last traded at GBX 38.99 ($0.53). 5,274,668 shares changed hands during trading, an increase of 183% from the average session volume of 1,863,729 shares. The stock had previously closed at GBX 34.95 ($0.47).
Avacta Group Stock Performance
The firm has a fifty day simple moving average of GBX 32.51 and a 200-day simple moving average of GBX 37.94. The company has a current ratio of 1.29, a quick ratio of 4.96 and a debt-to-equity ratio of 52.53. The stock has a market cap of £153.86 million, a price-to-earnings ratio of -5.21 and a beta of 1.12.
Avacta Group (LON:AVCT - Get Free Report) last posted its quarterly earnings results on Friday, June 6th. The biotechnology company reported GBX (8.54) (($0.12)) earnings per share for the quarter. Avacta Group had a negative net margin of 114.45% and a negative return on equity of 74.00%. Analysts forecast that Avacta Group Plc will post -9.9011833 EPS for the current fiscal year.
Avacta Group Company Profile
(
Get Free Report)
Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.
Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Avacta Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avacta Group wasn't on the list.
While Avacta Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
